Skip to Content

ULTRASE MT 18 (Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease)

Generic Name: pancrelipase

Pill with imprint ULTRASE MT 18 is Gray / White, Capsule-shape and has been identified as Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease. It is supplied by Axcan Scandipharm Inc..

Ultrase MT 18 is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for ULTRASE MT 18

Ultrase MT 18 58,500 units amylase; 18,000 units lipase; 58,500 units protease ULTRASE MT 18

Ultrase MT 18

Generic Name
pancrelipase
Imprint
ULTRASE MT 18
Strength
58,500 units amylase; 18,000 units lipase; 58,500 units protease
Color
Gray / White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Digestive enzymes
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Axcan Scandipharm Inc.
National Drug Code (NDC)
58914-0018

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.